Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes

Diabetes, Metabolic Syndrome and Obesity

Volumn 4, Issue , 2011, Pages 53-60

  Gunasekara, Priyanka ^a   Hettiarachchi, Manjula ^a   Liyanage, Chandrani ^a   Lekamwasam, Sarath ^a  

^a UNIVERSITY OF RUHUNA   (Sri Lanka)

Author keywords

Diabetes; Glycemic control; Multivitamin mineral supplementation; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; COLECALCIFEROL; COPPER; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; MAGNESIUM; MANGANESE; MULTIVITAMIN; RETINOL; SELENIUM; ZINC SULFATE;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; VITAMIN SUPPLEMENTATION;

EID: 79953111425     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S16691     Document Type: Article

References (29)

1. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998;17(2): 109-115.
2. Kinlaw W, Levine A, Morley J, et al. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. 1983;75:273-277.
3. Niewohner C, Allen J, Boosalis M, et al. Role of zinc supplementation in type II diabetes mellitus. Am J Med. 1986;81:63-68.
4. Roussel AM, Kerkeni A, Zouari N, et al. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr. 2003;22:316-321.
5. Anderson R, Roussel AM, Zouari N, et al. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr. 2001;20:212-218.
6. Faure P, Benhamou P, Perard A, et al. Lipid peroxidation in insulin dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr. 1995;49:282-288.
7. Soinio M, Marniemi J, Laakso M, et al. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care. 2007;30:523-528.
8. Hettiarachchi M, Liyanage C, Wickremasinghe R, et al. Nutrient intake and growth of adolescents in southern Sri Lanka. Cey Med J. 2006; 51(3):89-92.
9. Ministry of Health and Indigenous Medicine. Nutrition Guide. Sri Lanka: Ministry of Health and Indigenous Medicine; 2000.
10. Zinc, Bioassay Systems, Hayward, CA 94545, USA, 2007.
11. INS-EASIA, KAP 1251, BioSource Europe SA, Belgium, 2006.
12. Farvid MS, Jalali M, Siassi F, et al. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care. 2005;28:2458-2464.
13. Kazi TG, Afridi HI, Kazi N, et al. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. 2008;122:1-18.
14. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;20:3-18.
15. Heidarian E, Amini M, Parham M, et al. Effect of zinc supplementation on serum homocysteine in type 2 diabetic patients with microalbuminuria. Rev Diabet Stud. 2009;6(1):64-70.
16. Prasad AS. Zinc deficiency has been known of for 40 years but ignored by global health organizations. BMJ. 2003;326:409-410.
17. Singh RB, Mohammad AN, Rastogi SS, et al. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations in North India. J Am Coll Nutr. 1998;17:564-570.
18. King JC, Shames DM, Woodhouse LR. Zinc homeostasis in human. J Nutr. 2000;130:1360-1366.
19. Al-Maroof RA, Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J. 2006;27(3):344-350.
20. Hussain SA, Khadim HM, Khalaf BH, et al. Effect of melatonin and zinc on glycaemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J. 2006;27(10):1483-1488.
21. Wood RJ. Assessing marginal zinc deficiency: where are we now and where are we going in the future? J Nutr. 2000;130:S1350-S1354.
22. Klaus-Helge I, Lothar R. Zinc-altered immune function. J Nutr. 2003; 133:1452S-1456S.
23. Kadhim HM, Ismail SH, Hussein KI, et al. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res. 2006;41:189-193.
24. Partida-Hernández G, Arreola F, Fenton B, et al. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother. 2006;60:161-168.
25. Garber AJ, Karlsson FO. Treatment of dyslipidemia in diabetes. Endocrinol Metab Clin North Am. 2001;30:991-1010.
26. Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: implication for atherosclerosis. J Am Coll Nutr. 2001;20:91-105.
27. Garg JP. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vascular Medicine. 2002;7(1):35-43.
28. Hettiarachchi M, Liyanage C. Dietary macro- and micro- nutrient intake among a cohort of pre-school children from southern Sri Lanka. Cey Med J. 2010;55(2):47-52.
29. Baines SK, Roberts DCK. Undernutrition in the community. Austr Presc. 2001;24(5):113-115.